Variant report
Variant | esv1832833 |
---|---|
Chromosome Location | chr10:56467874-56494301 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs4935119 | chr10:56467874-56467875 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs368823546 | chr10:56467901-56467902 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs531084931 | chr10:56467943-56467944 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs560863988 | chr10:56467980-56467981 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs375842068 | chr10:56467990-56467991 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs372423560 | chr10:56468005-56468006 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs10763129 | chr10:56468045-56468046 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs79435936 | chr10:56468063-56468064 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs186039643 | chr10:56468074-56468075 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs528619829 | chr10:56468081-56468082 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs369586283 | chr10:56468132-56468133 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs4935120 | chr10:56468146-56468147 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs368783601 | chr10:56468241-56468242 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs565188313 | chr10:56468288-56468289 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs537298095 | chr10:56468316-56468317 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs530960030 | chr10:56468325-56468326 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs116239695 | chr10:56468341-56468342 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs190892290 | chr10:56468361-56468362 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs530398080 | chr10:56468377-56468378 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs547253094 | chr10:56468400-56468401 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs567062222 | chr10:56468434-56468435 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs538807430 | chr10:56468459-56468460 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs72794532 | chr10:56468486-56468487 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs182555333 | chr10:56468539-56468540 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs367569495 | chr10:56468540-56468541 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs373068066 | chr10:56468560-56468561 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs1572429 | chr10:56468563-56468564 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs574437724 | chr10:56468564-56468565 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs369082890 | chr10:56468565-56468566 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs58888332 | chr10:56468569-56468570 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs540127566 | chr10:56468574-56468575 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs58286973 | chr10:56468602-56468603 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs80337379 | chr10:56468635-56468636 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs539264275 | chr10:56468647-56468648 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs186830863 | chr10:56468649-56468650 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs147095066 | chr10:56468657-56468658 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs79467944 | chr10:56468662-56468663 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs11004453 | chr10:56468676-56468677 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs372562272 | chr10:56468732-56468733 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs191659030 | chr10:56468748-56468749 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs561254852 | chr10:56468752-56468753 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs183023252 | chr10:56468777-56468778 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs115100611 | chr10:56468820-56468821 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs567022876 | chr10:56468822-56468823 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs532755333 | chr10:56468926-56468927 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs187306849 | chr10:56468966-56468967 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs138467713 | chr10:56468998-56468999 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs74136247 | chr10:56469009-56469010 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs554185944 | chr10:56469010-56469011 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs76581197 | chr10:56469012-56469013 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Pancreatic endocrine tumor | 17639061 | CNVD |
Gastric cancer | 17908304 | CNVD |
Chordoma | 21602918 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Melanoma | 18172304 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 20724749 | CNVD |
Autism | 22495311 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Prostate cancer | 18632612 | CNVD |
Autism | 18414403 | CNVD |
Cockayne syndrome | 18421352 | CNVD |
Glioblastoma | 16823260 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Neuroblastoma | 17533364 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Glioma | 21971842 | CNVD |
Cancer | 21637783 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Obesity | 21956041 | CNVD |
Developmental delay | 21948486 | CNVD |
Intellectual disability | 21948486 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21364760 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Autism | 20841430 | CNVD |
Mental retardation | 17124404 | CNVD |
Epilepsy | 20923578 | CNVD |
Prostate cancer | 16573809 | CNVD |
Schizophrenia | 19329560 | CNVD |
Heart failure | 18772530 | CNVD |
Heart failure | 18854381 | CNVD |
Hyperglycemia | 19060297 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Usher syndrome | 20538994 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Autism | 20858243 | CNVD |
Breast cancer | 22522925 | CNVD |
Usher type I cohort | 17277737 | CNVD |
Usher type I cohort | 21436283 | CNVD |
Leukemia | 21357790 | CNVD |
Medulloblastoma | 22832581 | CNVD |
Cancer | 20164919 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr10:56466400-56471000 | Enhancers | Fetal Lung | lung |
2 | chr10:56466600-56469000 | Enhancers | Fetal Brain Male | brain |
3 | chr10:56467600-56468800 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
4 | chr10:56468600-56469200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
5 | chr10:56469200-56470600 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
6 | chr10:56470600-56471000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
7 | chr10:56471000-56472000 | Weak transcription | Fetal Lung | lung |
8 | chr10:56472200-56472400 | Enhancers | Fetal Lung | lung |